Smoking impacts patients undergoing peripheral artery disease

Published On 2021-10-12 12:08 GMT   |   Update On 2022-12-12 07:22 GMT

Smoking is a key modifiable risk factor in the development and progression of peripheral artery disease, which often manifests as intermittent claudication (IC). Smoking cessation is a first-line therapy for IC, yet a minority of patients quit smoking prior to elective revascularization.

In an online issue of JAMA Cardiology Reitz et al have reported that smoking is associated with an increased risk of early postprocedural complications following open and endovascular interventions for IC. The study thus emphasizes smoking cessation prior to elective revascularization for IC.

For more details, check out the full story on the link below:



Full View
Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News

Health Bulletin 17/ July/ 2024